Pioglitazone

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 7907 publications

Association of pioglitazone versus dipeptidyl peptidase-4 inhibitor use with incident gout in type 2 diabetes: a real-world cohort study.

Association of pioglitazone versus dipeptidyl peptidase-4 inhibitor use with incident gout in type 2 diabetes: a real-world cohort study.

Journal: Acta clinica Belgica

Published: August 10, 2026

Predicting pHmax and Salt Disproportionation Risk for Basic Drugs.

Predicting pHmax and Salt Disproportionation Risk for Basic Drugs.

Journal: Molecular pharmaceutics

Published: July 23, 2026

Pharmacologic Treatments for MASLD: A Review of Efficacy and Safety Considerations.

Pharmacologic Treatments for MASLD: A Review of Efficacy and Safety Considerations.

Journal: The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians

Published: July 22, 2026

Temporal trends and clinical factors associated with hypoglycemia-related hospitalization of patients with type 2 diabetes: a large-scale claims database study in Japan.

Temporal trends and clinical factors associated with hypoglycemia-related hospitalization of patients with type 2 diabetes: a large-scale claims database study in Japan.

Journal: Diabetes research and clinical practice

Published: July 17, 2026

Comparative Effectiveness of Glucagon-like Peptide-1 Receptor Agonists Versus Oral Agents for Insulin Discontinuation in Type 2 Diabetes : A Target Trial Emulation.

Comparative Effectiveness of Glucagon-like Peptide-1 Receptor Agonists Versus Oral Agents for Insulin Discontinuation in Type 2 Diabetes : A Target Trial Emulation.

Journal: Annals of internal medicine

Published: July 13, 2026

Disease-modifying anti-diabetic drugs (DMADDs): bridging the SIMPLE approach to disease interception.

Disease-modifying anti-diabetic drugs (DMADDs): bridging the SIMPLE approach to disease interception.

Journal: Cardiovascular diabetology

Published: July 09, 2026

Efficacy and Safety of Pioglitazone Added to Metformin and SGLT2 Inhibitors in Type 2 Diabetes: An Updated Systematic Review and Meta-analysis.

Efficacy and Safety of Pioglitazone Added to Metformin and SGLT2 Inhibitors in Type 2 Diabetes: An Updated Systematic Review and Meta-analysis.

Journal: The Annals of pharmacotherapy

Published: June 28, 2026

Adipose Tissue Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Adipose Tissue Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Cells

Published: June 25, 2026

Correction to "Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?"

Correction to "Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?"

Journal: PPAR research

Published: June 24, 2026

Pioglitazone in Skin Fibrosis: Mechanistic Rationale and Therapeutic Potential of Pioglitazone for Scarring Dermatoses.

Pioglitazone in Skin Fibrosis: Mechanistic Rationale and Therapeutic Potential of Pioglitazone for Scarring Dermatoses.

Journal: Journal of visualized experiments : JoVE

Published: June 22, 2026

Targeted activation of PPARG or AKT1 alleviates liver injury in mice with type 2 diabetes and sepsis by modulating inflammatory and metabolic pathways.

Targeted activation of PPARG or AKT1 alleviates liver injury in mice with type 2 diabetes and sepsis by modulating inflammatory and metabolic pathways.

Journal: Annals of medicine

Published: June 19, 2026

Investigating the stereological and oxidative stress effects of hydroalcoholic extracts of Cynara scolymus L. and pioglitazone on diabetic rat ovary.

Investigating the stereological and oxidative stress effects of hydroalcoholic extracts of Cynara scolymus L. and pioglitazone on diabetic rat ovary.

Journal: Zygote (Cambridge, England)

Published: June 18, 2026

Showing 1-12 of 7,907

Last Updated: 09/26/2026